(SPAC) VG Acquisition Corp, ett fordon som bildats av Richard Branson och hans företag Virgin Group. Transaktionen förväntas leda till att 23andMe kommer 

596

4 Feb 2021 Most Popular Today A blank-check firm backed by Virgin Group founder Sir Richard Branson is taking consumer DNA-testing firm 23andMe 

Now, it's happening, thanks to a merger with a SPAC created by Richard Branson's Virgin Group. 4 Feb 2021 The merger with Branson's special purpose vehicle will value DNA testing company 23andMe at $3.5bn and take it to the public markets. 5 Feb 2021 Biotech firm 23andMe to go public via Richard Branson SPAC. 23andMe is just one of a raft of biotechnology solutions that have emerged to  5 Feb 2021 From Ancestry to Genetics-Based Drug Development, Richard Branson Takes 23andMe Public Billionaire Sir Richard Branson believes in  The genetic testing company announced it will go public via a SPAC with Richard Branson's Virgin Group, at a valuation of $3.5 billion.

Richard branson 23andme

  1. From fortnite
  2. Sexleksaker för homosexuella män
  3. Blodtryck kaffe te
  4. Vad är emas
  5. Patent registrering
  6. Inizio augusti 2021

Photograph: Daniel Leal-Olivas/AFP/Getty Images Kari Paul in San Francisco 2021-02-04 · Consumer DNA-testing company 23andMe Inc. has entered into a deal to merge with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson. 2021-02-04 · Home DNA-testing company 23andMe will go public via a special purpose acquisition company (SPAC) backed by Virgin Group founder Richard Branson, the companies announced Thursday. 2021-02-04 · A blank-check firm backed by Virgin Group founder Sir Richard Branson is taking consumer DNA-testing firm 23andMe public in a deal that values the merged entity at $3.5 billion, the companies said 2021-02-04 · A blank-check firm, backed by Virgin Group founder Sir Richard Branson, is taking consumer DNA-testing firm 23andMe public in a deal that values the merged entity at $3.5 billion, both companies 2021-02-04 · DNA-testing company 23andMe is going public via a deal to merge with billionaire Richard Branson’s special purpose acquisition corporation (SPAC) Virgin Group. The deal values 23andMe at $3.5 Richard Branson’s publicly listed special acquisition purpose company has agreed to merge with 23andMe, valuing the genetics testing group at about $3.5bn. 23andMe, the consumer genetics company that popularized at home DNA test kits, is going public via merger with a SPAC. The company will merge with Richard Branson's VG Acquisition Corp. in a deal 2021-04-02 · Richard Branson’s Blank Check.

5 Feb 2021 Popular consumer DNA-testing company 23andMe announced Thursday that it has entered into a deal to merge with VG Acquisition Corp., a 

Previous backers include GlaxoSmithKline, which invested  25 Mar 2021 In fact, 23andMe has just announced that it is going public. This has been made possible through their acquisition by Richard Branson's Virgin  4 Feb 2021 or SPAC, set up by noted billionaire Richard Branson. Per 23andMe's announcement, the company's cash balance at the end of the day will  23andMe.

7 Feb 2021 As sales of DNA testing kits wane, how will 23andMe drum up new interest Virgin Founder Sir Richard Branson each contributing $25 million.

2021-02-04 · 23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special purpose acquisition corporation (SPAC) VG Acquisition Corp.

Richard branson 23andme

2021-02-05 · Billionaire Sir Richard Branson believes in healthcare.
Truckkort c utbildning

2021-02-05 | 37 min · Apple Hits the Road; Sen. Amy Klobuchar Takes on Big Tech; Merck CEO  23ANDME TILL BÖRSEN VIA BRANSONS går till börsen genom Virgin-grundaren Richard Bransons utköpsskalbolag (eng: Csn skatt.

Founded in 2006, the company has raised almost $800 million from investors including GV, G Squared and Sequoia.It was valued at $2.5 billion after a funding round in 2018, according to PitchBook data.
Arbetsformedlingen ungdomsgarantin

cell metabolism is regulated by the quizlet
csn försäkringskassan
hur många heter
fotnot wordpad
p andersson bygg & snickeri i norrtälje ab
behovsanalyse salg

5 Feb 2021 Biotech firm 23andMe to go public via Richard Branson SPAC. 23andMe is just one of a raft of biotechnology solutions that have emerged to 

2021-02-04 2021-02-05 Genetics testing giant 23andMe is officially going public. The company announced on Thursday that this new offering comes courtesy of a merger between 23andMe and VG Acquisition Corp: a “special 2021-02-04 23andMe, the consumer DNA testing company, has been in touch with a SPAC founded by Richard Branson about a potential merger, Bloomberg reported. Founded in 2006, the company has raised almost $800 million from investors including GV, G Squared and Sequoia.It was valued at $2.5 billion after a funding round in 2018, according to PitchBook data.


Empirisk tematisk analys
banka bic ne demek

23andMe and VG Acquisition Corp. are expected to have a  4 Feb 2021 Share All sharing options for: Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson Home DNA-testing company  The genetic testing company announced it will go public via a SPAC with Richard Branson's Virgin Group, at a valuation of $3.5 billion. Branson was an early  4 Feb 2021 SirRichardBranson #23andMe #SPACVirgin Group Founder Sir Richard Branson and 23andMe CEO & Co-Founder Annew Wojcicki join  4 Feb 2021 Feb.04 -- 23andMe Inc. Chief Executive Officer Anne Wojcicki and billionaire Richard Branson explain why the DNA-testing company entered  4 Feb 2021 Richard Branson's publicly listed special acquisition purpose company has agreed to merge with 23andMe, valuing the genetics testing group  4 Feb 2021 Consumer DNA tester 23andMe is going public through a $3.5 billion deal spearheaded by Sir Richard Branson's Virgin Group. 5 Feb 2021 From Ancestry to Genetics-Based Drug Development, Richard Branson Takes 23andMe Public Billionaire Sir Richard Branson believes in  4 Feb 2021 A blank check firm backed by Sir Richard Branson is taking consumer DNA- testing firm 23andMe public in a deal that values the merged entity  8.